ALAihong Li

Aihong Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aihong Li has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Aisong Guo

    Department of Traditional Chinese Medicine, Affiliated Hospital of Nantong University, Nantong, China

    1 shared publication
  • Dingding Shen

    Department of Neurology in Affiliated Hospital of Nantong University, Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Medical school, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China

    1 shared publication
  • Haijiao Ye

    Department of Neurology, Affiliated Hospital of Nantong University, Nantong University, Nantong, China

    1 shared publication
  • Jiayu Chen

    Department of Neurology, Affiliated Hospital of Nantong University, Nantong University, Nantong, China

    1 shared publication
  • Jie Zhang

    Department of Neurology, Affiliated Hospital of Nantong University, Nantong University, Nantong, China

    1 shared publication
  • Jing Zhou

    Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China

    1 shared publication

Latest Publications

  • Beyond Impaired GABAergic Signaling: Inflammation and Metabolic Dysfunction in Genetic Epilepsy Induced by GABRG2 Mutation

    by Dingding Shen, Wenwen Wu, Jing Zhou, Xin Zhang, Longwu Zhan, Peipei Qian, Jingjing Qian, Aisong Guo, Aihong Li, Qi Zhang

    Although the mechanisms underlying genetic epilepsies associated with mutations in the γ-aminobutyric acid type A receptor γ2 subunit gene (GABRG2) have been extensively investigated, prior studies primarily focused on the functional alterations of mutant ion channels. Emerging evidence has indicated that neuroinflammation and metabolic disturbances are involved in acquired epilepsies. To further investigate the potential involvement of these mechanisms in genetic epilepsies, we generated a transgenic zebrafish line, Tg(hGABRG2I107T), harboring the GABRG2(I107T) mutation associated with developmental and epileptic encephalopathies. The Tg(hGABRG2I107T) zebrafish exhibited spontaneous seizure-like behaviors and hyperexcitability as demonstrated by electrophysiological recordings and elevated c-fos transcript levels. Total γ2 subunit expression increased and its cell membrane localization was reduced. These zebrafish also displayed disrupted neuronal marker expression and abnormal synaptic ultrastructure, indicative of an excitatory/inhibitory imbalance. Transcriptome analysis revealed that differentially expressed genes in the brain were enriched in the endoplasmic reticulum (ER) protein processing, metabolic pathway, and TGF-β signaling pathway. Pro-inflammatory factors were upregulated, while genes involved in the tricarboxylic acid (TCA) cycle were downregulated. Similarly, HEK293T cells transfected with the mutant γ2(I107T) exhibited significant reductions in TCA-related gene expression, ATP levels, and mitochondrial density. In addition to impairing receptor trafficking, the γ2(I107T) mutation may induce ER stress, and disrupt inflammatory and metabolic pathways, thereby leading to an imbalance of excitatory/inhibitory neurotransmission and potentially contributing to the pathogenesis of genetic epilepsy. Pharmacological intervention with dexamethasone and INCB3344, a C–C chemokine receptor type 2 antagonist, ameliorated seizure-like behavior in Tg(hGABRG2I107T) zebrafish, further supporting the causal role of neuroinflammation in epileptogenesis in genetic epilepsy.


  • Open Access

    Pathogenesis of seizures and epilepsy after stroke

    by Jiayu Chen, Haijiao Ye, Jie Zhang, Aihong Li, Yaohui Ni

    Stroke is the most frequent cause of secondary epilepsy in the elderly. The incidence of cerebral stroke is increasing with the extension of life expectancy, and the prevalence of post-stroke epilepsy (PSE) is rising. There are various seizure types after stroke, and the occurrence of epilepsy is closely related to the type and location of stroke. Moreover, the clinical treatment of post-stroke epilepsy is difficult, which increases the risk of disability and death, and affects the prognosis and quality of life of patients. Now seizure and epilepsy after stroke is more and more get the attention of the medical profession, has been more and more researchers have devoted to seizures after stroke and PSE clinical and basic research, and hope to get a scientific and unified guideline, to give timely and effective treatment, but the exact pathophysiologic mechanism has not yet formed a unified conclusion. It has been found that ion channels, neurotransmitters, proliferation of glial cells, genetics and other factors are involved in the occurrence and development of PSE. In this review, we discuss the pathogenesis of early-onset epileptic seizures and late-onset epilepsy after stroke, in order to provide a basis for clinicians to understand the disease, and expect to provide ideas for future exploration.